Issue 31, 2021

Generation of a quenched phosphonate activity-based probe for labelling the active KLK7 protease

Abstract

Kallikrein 7 (KLK7) is a chymotrypsin-like serine protease with established roles in skin diseases like the rare Netherton syndrome, an overdesquamating and inflammatory condition, but also common atopic dermatitis, and a potential drug target for these and possibly other diseases. Nevertheless, tools to determine the active KLK7 enzyme are not available. Here, a mixed alkyl aryl phosphonate quenched activity-based probe that detects the active KLK7 was developed and evaluated in vitro. This KLK7-qABP can potentially be used to monitor KLK7 activity in vivo.

Graphical abstract: Generation of a quenched phosphonate activity-based probe for labelling the active KLK7 protease

Supplementary files

Article information

Article type
Paper
Submitted
01 Jul 2021
Accepted
19 Jul 2021
First published
19 Jul 2021
This article is Open Access
Creative Commons BY license

Org. Biomol. Chem., 2021,19, 6834-6841

Generation of a quenched phosphonate activity-based probe for labelling the active KLK7 protease

E. Bisyris, E. Zingkou, G. G. Kordopati, M. Matsoukas, P. A. Magriotis, G. Pampalakis and G. Sotiropoulou, Org. Biomol. Chem., 2021, 19, 6834 DOI: 10.1039/D1OB01273H

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements